|
|||||
|
|
Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib |
|
| Authors: | César Serrano Xavier García-del-Muro Claudia Valverde Ana Sebio José Durán Aránzazu Manzano Isabel Pajares Nadia Hindi Stefania Landolfi Laura Jiménez Jordi Rubió-Casadevall Anna Estival Javier Lavernia María José Safont Carles Pericay Roberto Díaz-Beveridge Virginia Martínez-Marín David Vicente-Baz Ana Vivancos Javier Hernández-Losa Joaquín Arribas Joan Carles |
| Affiliation: | 1. Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain;2. Medical Oncology Department, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, Spain CIBERONC, Madrid, Spain;3. Medical Oncology Department, Sant Pau Hospital, Barcelona, Spain;4. Medical Oncology Department, Son Espases Hospital, Palma de Mallorca, Spain;5. Medical Oncology Department, San Carlos University Hospital, Madrid, Spain;6. Medical Oncology Department, Miguel Servet Hospital, Zaragoza, Spain;7. Medical Oncology Department, Virgen del Rocío Hospital, Sevilla, Spain;8. Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain CIBERONC, Madrid, Spain;9. Medical Oncology Department, Catalan Institute of Oncology, IDIBELL, L'Hospitalet, Spain;10. Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain;11. Medical Oncology Department, Catalan Institute of Oncology, Badalona, Spain;12. Medical Oncology Department, Oncology Institute of Valencia, Valencia, Spain;13. CIBERONC, Madrid, Spain Medical Oncology Department, Valencia General Hospital, Valencia, Spain;14. Medical Oncology Department, Parc Tauli University Hospital, Sabadell, Spain;15. Medical Oncology Department, La Fe University Hospital, Valencia, Spain;16. Medical Oncology Department, La Paz University Hospital, Madrid, Spain;17. Medical Oncology Department, Virgen Macarena Hospital, Sevilla, Spain;18. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain;19. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain CIBERONC, Madrid, Spain Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain Contributed equally;20. Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain Universitat Internacional de Catalunya, Barcelona, Spain Contributed equally |
| Abstract: | |
| Keywords: | c-KIT Gastrointestinal stromal tumor Imatinib mesylate Long-term |